Trial Profile
Safety and efficacy of Sirolimus /Everolimus in Lung Transplantation at Recipients With Lymphangioleiomyomatosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Apr 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary)
- Indications Lymphangioleiomyomatosis
- Focus Therapeutic Use
- 25 Apr 2018 New trial record
- 14 Apr 2018 Results presented at the 38th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation